Kip3 clusters kinetochores
- 期刊名称Cell Cycle
- 作者Rizk, Rania S.; Gupta, Mohan L.
- 卷第9卷
- 期第13期
- 印刷ISSN1538-4101
- 电子ISSN1551-4005
- 文件大小784.01KB
- 发表时间2010-07
- DOI10.4161/cc.9.13.12273
- 页码2491-2501
Effect of roscovitine, a selective cyclin B-dependent kinase 1 inhibitor, on assembly of the nucleolus in mitosisO. O. Zharskaya; A. S. Barsukova; O. V. Zatsepina · 2008
The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHDLi, Lequn; Wang, Hui; Kim, Jin sub; Pihan, German; Boussiotis, Vassiliki A. · Cell Cycle · 2009
Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor RoscovitineVidela-Richardson, Guillermo A.; Furmento, Verónica A.; Garcia, Carolina P.; Morris-Hanon, Olivia; Sevlever, Gustavo E.; Romorini, Leonardo; Scassa, María E. · BMC Molecular and Cell Biology · 2019
In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)Steven J. McClue; David Blake; Rosemary Clarke; Angela Cowan; Lorna Cummings; Peter M. Fischer; Mairi MacKenzie; Jean Melville; Kevin Stewart; Shudong Wang; Nikolai Zhelev; Daniella Zheleva; David P. Lane · 2002
422 The mode of action of CYC202 (R-roscovitine) a cyclin dependent kinase inhibitor currently in phase II clinical trialsS. Green; D.E. MacCallum; I.N. Fleming; J. Melville; M. Watson; S. Frame; K. Watt; S. Anderson; A. Gianella-Borradori; D.P. Lane · 2004
The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectorsNellore, Anoma; Liu, Bianling; Patsoukis, Nikolaos; Boussiotis, Vassiliki A.; Li, Lequn · Clinical Immunology · 2014
Clusters, factories and domainsGillespie, Peter J.; Blow, Julian · Cell Cycle · 2010
p53 in autophagy controlZong, Wei-Xing; Moll, Ute · Cell Cycle · 2008
From oncogene to tumor suppressorUribesalgo, Iris; Benitah, Salvador Aznar; Di Croce, Luciano · Cell Cycle · 2012
The Mitotic Checkpoint in Cancer TherapyTao, Weikang · Cell Cycle · 2005
Thiostrepton, proteasome inhibitors and FOXM1Gartel, Andrei L. · Cell Cycle · 2011
Sumoylation fights “aggregopathies”Krumova, Petranka; Weishaupt, Jochen H. · Cell Cycle · 2012
Barrett esophagusQuante, Michael; Abrams, Julian A.; Lee, Yoomi; Wang, Timothy C. · Cell Cycle · 2012
Autophagy and cardiovascular agingNair, Sreejayan; Ren, Jun · Cell Cycle · 2012